About Mayinglong Pharmaceutical Group Company

The company (600993.SH) was founded in 1582 AD and is a “time-honored Chinese brand” enterprise that has continued to operate for 440 years. Adhering to the development idea of “unifying target customers and diversifying service functions”, the company is committed to providing customers with specialized, personalized and diversified anorectal health solutions, vigorously developing the big health industry, and forming a group enterprise integrating the four major business segments of pharmaceutical industry, big health, medical services, and pharmaceutical business. The company focuses on the anorectal and lower digestive tract fields, creates a provider of anorectal health solutions, and vigorously develops the big health industry. Through the deepening implementation of the brand management strategy, the industrial chain was extended to the diagnosis and treatment industry according to the development idea of “unification of target customers and diversification of service functions”, Internet medical care was vigorously developed, and development opportunities were actively sought around the health sector, and the industrial layout of the pharmaceutical industry, medical services, and pharmaceutical business was formed. The company owns more than 10 exclusive drugs, such as Ma Yinglong Musk Hemorrhoid Cream, Musk Hemorrhoid Suppositories, Ma Yinglong Babao Eye Cream, and Dragon Ball Ointment. The company's qualifications and honors include the Order of the Chinese Red Cross Society, the China 500 Most Valuable Brand Certificate (22,857 billion yuan), the China 500 Most Valuable Brand Medal, private enterprises with outstanding contributions, and the Hubei Intelligent Manufacturing Demonstration Unit in 2017.6.